ViewRay, Inc. (VRAYQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Nov 18, 2024, 3:00 PM EST
ViewRay Revenue
ViewRay had revenue of $22.53M in the quarter ending March 31, 2023, with 19.38% growth. This brings the company's revenue in the last twelve months to $105.86M, up 44.09% year-over-year. In the year 2022, ViewRay had annual revenue of $102.21M with 45.76% growth.
Revenue (ttm)
105.86M
Revenue Growth
+44.09%
P/S Ratio
n/a
Revenue / Employee
358.86K
Employees
295
Market Cap
183.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 102.21M | 32.09M | 45.76% |
Dec 31, 2021 | 70.12M | 13.10M | 22.98% |
Dec 31, 2020 | 57.02M | -30.77M | -35.05% |
Dec 31, 2019 | 87.78M | 6.82M | 8.42% |
Dec 31, 2018 | 80.96M | 46.92M | 137.83% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Medexus Pharmaceuticals Inc. | 104.76M |